About Element Biosciences
Element Biosciences is a company based in Sunnyvale (United States) founded in 2015 was acquired by Element Biosciences in February 2022. It operates as a Product-as-a-Service and Direct-to-Consumer (D2C). Element Biosciences has raised $8.12 million across 3 funding rounds from investors including Element Biosciences, Khosla Ventures and Wilson Sonsini Goodrich & Rosati. Element Biosciences offers products and services including AVITI24, Cloudbreak Sequencing Kits, and ElemBio Cloud. Element Biosciences operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
- Headquarter Sunnyvale, United States
- SectorsHealthcare
- Phone•••• ••••
- Website loopgenomics.com
- Social LinkedIn YouTube
- Acquired by Element Biosciences (Feb 2022)
- Legal Name Element Biosciences
- Total Equity Funding$8.12M (USD)
in 3 rounds
- Latest Funding Round$8M (USD), Series A
Nov 2018
- InvestorsElement Biosciences
& 6 more
- Acquired byElement Biosciences
(Feb 2022)
Products & Services of Element Biosciences
Element Biosciences offers a comprehensive portfolio of products and services, including AVITI24, Cloudbreak Sequencing Kits, and ElemBio Cloud.
Advanced system for 5D multiomics biological analysis.
Kits designed for high-quality sequencing applications.
Platform for managing and analyzing sequencing data.
Apps and channels of Element Biosciences
its YouTube channel Element Biosciences has 481 subscribers and 30 videos.
Videos from Element Biosciences
The most watched videos on Element Biosciences's YouTube channel, Element Biosciences (481 subscribers). Click a video to play it here.
More on Element Biosciences.
Funding Insights of Element Biosciences
Element Biosciences has successfully raised a total of $8.12M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.12M
- Total Rounds 3
- Last Round Series A — $8M
- First Round $120,000
(Nov 2015)
- Investors Count 6
All 3 funding rounds of Element Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | $8M | Series A | – | Khosla Ventures, Fusion Fund | |
| Feb 2018 | – | Seed | – | – | |
| Nov 2015 | $120,000 | Seed | – | – |
7 investors in total: 7 institutional.
Investors in Element Biosciences
Element Biosciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Element Biosciences, Khosla Ventures and Wilson Sonsini Goodrich & Rosati.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Investment in early-stage startups focusing on healthcare, AI, and industrial technology. | – | fusionfund.com | - | |
Venture capital firm focused on software, fintech, marketplaces, and consumer internet | – | dncapital.com | London, United Kingdom | |
Early-stage startups are accelerated via funding and educational programs. | – | ycombinator.com | Mountain View, United States | |
US focused seed & early stage VC firm | – | wisemontcapital.com | Belmont, United States | |
Provider of legal services to technology and life science companies | 1961 | wsgr.com | Palo Alto, United States | |
Benchtop DNA sequencers are developed for research and diagnostic uses. | 2017 | elementbiosciences.com | San Diego, United States |
Investor details for Element Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Element Biosciences
4 people are tracked at Element Biosciences (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Shawn Levy | Chief Scientific Officer And SVP Of Applications | Leadership |
Michael Previte | Cto, SVP Of R&d, And Co-founder | Leadership |
Francisco Garcia | SVP Of Informatics | Team |
Caroline Obert | Staff Study Manager | Team |
Complete people profiles for Element Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Element Biosciences
4 dated milestones of Element Biosciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Element Biosciences is founded.
- Funding First funding round of $120K.
- Funding Latest funding round, Series A, of $8.0M.
- Exit Acquired by Element Biosciences.
Competitors of Element Biosciences
Element Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanoporetech.com | 2005 | Oxford, United Kingdom | $1.26B | 705 | Nanopore-based electronic systems for single-molecule analysis are developed. | |
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. | |
| genapsys.com | 2010 | Redwood, United States | $313.03M | 60 | Provider of DNA sequencing technologies for applied genomic testing and medical sequencing | |
| raindancetech.com | 2004 | Billerica, United States | $111.66M | 105 | Developer of nucleic acid detection and quantification systems | |
| quantumdx.com | 2008 | Newcastle Upon Tyne, United Kingdom | $57.26M | 98 | Handheld diagnostic and sequencing devices are developed for personalized healthcare. | |
| tierrabiosciences.com | 2015 | Berkeley, United States | $31.56M | 11 | AI-based tools for protein development and custom synthesis are offered. | |
| purigenbio.com | 2012 | Pleasanton, United States | $88.32M | 24 | Isotachophoresis technology is provided for nucleic acid sample preparation. | |
| stratosgenomics.com | 2007 | Seattle, United States | $62.89M | 64 | Nanopore-based single molecule sequencers are developed using SBX technology. |
Detailed competitors of Element Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Element Biosciences
Complete news archive for Element Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Element Biosciences
10 companies that operate in the same segment as Element Biosciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Element Biosciences
Element Biosciences was founded in 2015.
Element Biosciences is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Element Biosciences is a funded company, having raised a total of $8.12M across 3 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Nov 2015.
Element Biosciences is engaged in developing innovative genomic sequencing solutions. The company operates within the biotechnology sector, offering instruments, reagents, kits, and software for multiomics research. Products like AVITI24 enable spatial and single-cell co-detection of RNA, protein, and morphology. Their technology supports applications in DNA and RNA sequencing, long-read sequencing, and focus areas such as agricultural biology and pharmaceuticals. Solutions are designed to provide high-quality, affordable sequencing for scientific communities.
Element Biosciences offers AVITI24, Cloudbreak Sequencing Kits, and ElemBio Cloud.
Element Biosciences has 7 investors. Key investors include Element Biosciences, Khosla Ventures, Wilson Sonsini Goodrich & Rosati, Fusion Fund, and DN Capital.
Element Biosciences operates through Element Biosciences.
Yes. Element Biosciences was acquired by Element Biosciences in February 2022.